Skip to main content
    I

    In8bio Inc (INAB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.82
    +0.00 (+0.49%)

    Market Cap: $8.82M

    Last updated: Nov 17, 2026 at 4:13 PM ET

    In8bio Inc (INAB) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    In8bio (INAB) has a market cap of $8.82M. Its share count is up 329.14% from a year earlier. It holds $13.97M more cash than debt, 158.43% of its market cap.

    Total Valuation

    Market Cap$8.82M
    Latest price (Nov 17, 2026)$0.82

    Key Dates

    The next earnings report is expected on Mar 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 10, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.03% in the quarter ended Sep 30, 2026.

    Shares Outstanding19.47M
    Shares Change (YoY)+329.14%
    Shares Change (QoQ)+0.03%

    Price Statistics

    The stock is down 48.43% over 52 weeks and trades 24.77% below its 50-day average.

    Beta (1Y)1.40
    52-Week Change-48.43%
    1-Month Change-24.77%
    3-Month Change-31.67%
    6-Month Change-43.45%
    5-Year Change-99.60%
    Total Return (1Y)-48.43%
    Total Return (3Y CAGR)-68.91%
    Total Return (5Y CAGR)-67.23%
    Max Drawdown (1Y)-68.49%
    Max Drawdown (3Y)-98.84%
    Sharpe Ratio (1Y)-0.82
    Correlation with SPY (1Y)0.23
    50-Day Average$1.09
    200-Day Average$1.37
    52-Week Range$0.72 to $2.73
    RSI (14 Days)35.2
    Average Volume (20 Days)293.78K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.78x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio5.78x
    Quick Ratio5.78x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -136.91% and return on assets is -103.80% over the last 12 months.

    Return on Equity (ROE)-136.91%
    Return on Assets (ROA)-103.80%
    Return on Capital Employed (ROCE)-120.78%
    ROA (5Y Average)-83.12%
    ROIC (5Y Average)-55.73%

    Scores

    INAB has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $0 over the last 12 months is down 100.00% from the 12 months before.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Gross Profit-$1.17M
    Operating Income-$19.41M
    Pretax Income-$19.41M
    Net Income-$19.41M
    EBITDA-$17.49M
    EBIT-$19.41M
    Reported EPS (TTM)-$1.20

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 75.78% of the $18.70M in total assets.

    Cash and Equivalents$13.97M
    Total Debt$0
    Net Cash$13.97M
    Net Cash Per Share$0.72
    Working Capital$12.57M
    Shareholder Equity$14.17M
    Book Value Per Share$0.73
    Total Assets$18.70M
    Total Liabilities$4.52M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $243.00K of capital spending, operating cash flow left -$15.00M of free cash flow.

    Operating Cash Flow-$14.76M
    Capital Expenditures$243.00K
    Free Cash Flow-$15.00M
    FCF Per Share-$1.52
    Depreciation and Amortization$1.91M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    INAB does not pay a dividend.

    Buyback Yield-115.84%
    Shareholder Yield-115.84%

    Stock Splits

    The last split was a 1-for-30 reverse split on Jun 6, 2025.

    Last Split DateJun 6, 2025
    Split TypeReverse split
    Split Ratio1:30

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About INAB

    What is INAB's market cap?

    In8bio has a market cap of $8.82M.

    How many shares of INAB are outstanding?

    In8bio has 19.47M shares outstanding. The count is up 329.14% from a year earlier.

    Does INAB pay a dividend?

    No. In8bio does not pay a dividend.

    How much debt does INAB have?

    In8bio has $0 of total debt and $13.97M of cash and equivalents, a net cash position of $13.97M.